Alembic Pharmaceuticals gains as its arm incorporates wholly-owned subsidiary in USA
Alembic Pharmaceuticals is currently trading at Rs. 835.00, up by 13.15 points or 1.60% from its previous closing of Rs. 821.85 on the BSE.
The scrip opened at Rs. 842.40 and has touched a high and low of Rs. 843.25 and Rs. 822.15 respectively. So far 1386 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1296.15 on 09-Oct-2024 and a 52 week low of Rs. 725.60 on 03-Mar-2025.
Last one week high and low of the scrip stood at Rs. 843.25 and Rs. 796.95 respectively. The current market cap of the company is Rs. 16537.84 crore.
The promoters holding in the company stood at 69.61%, while Institutions and Non-Institutions held 20.23% and 10.16% respectively.
Alembic Pharmaceuticals’ wholly owned subsidiary -- Alembic Global Holding SA has incorporated a wholly-owned subsidiary in USA, named Alembic Lifesciences Inc. Alembic Global Holding SA will be making a remittance to Alembic LifeSciences Inc. towards subscription of 100% shareholding.
Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.
